Rybelsus®
Rybelsus® is the first and only GLP-1 receptor agonist available in a pill form, making it an excellent choice for those who prefer to avoid injections.
Compounded Tirzepatide is no longer available.
However, we’re proud to offer several excellent options.
Our team will work with you to find the safest and most effective treatment that fits your goals, preferences, and budget”
Alternative GLP-1 and GIP/GLP-1 Medications
Zepbound®
A once-weekly injectable Tirzepatide, a dual GLP-1 and GIP receptor agonist, indicated for Type 2 diabetes and approved for weight loss management.
Semaglutide
A once-weekly injectable GLP-1 receptor agonist that mirrors the active ingredient in Wegovy/Ozempic, typically compounded for cost-effective weight loss management.
Wegovy®
A once-weekly injectable GLP-1 receptor agonist (Semaglutide) specifically approved for chronic weight management in adults with obesity or overweight.
Ozempic®
A once-weekly injectable GLP-1 indicated for the treatment of Type 2 diabetes, and is safe and effective for weight loss.
Mounjaro®
A once-weekly injectable GLP-1 and GIP receptor agonist indicated for the treatment of Type 2 diabetes and is safe and effective for weight loss.
